Study searches for genetic markers to enhance the treatment of pregnant women with opioid use disorder and their neonates
Using a whole exome sequencing approach to enhance the treatment of pregnant women with opioid use disorder and their neonates.
School, Department, or Center
School of Medicine, Department of Behavioral Medicine & Psychiatry
Laura Lander, MSW
In this study, we will conduct a search for genetic markers in mothers and in their babies that are predictive of the clinical outcomes for babies with NAS. We will also explore what evidence-based protocols are most effective for the treatment of NAS. This project has two distinct but related aims.
Aim 1: Determine the genetic profiles from mother-baby dyads for women active in medication-assisted treatment programs whose babies are at risk for developing NAS.
Aim 2: Explore the most effective protocols for the treatment of NAS, with specific attention to medication used, mothers’ substance use treatment outcomes and the role of breastfeeding.
Statewide« Back to Research Initiatives